Clinical Trials Browser

Phase 2 × OTHER × Liposarcoma, Myxoid × Clear all

Liposarcoma, Liposarcoma, Myxoid

NCT02821507 2022-04-20

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

Phase 2 Completed

70 enrolled

Sarcoma

Liposarcoma, Myxoid, Chondrosarcoma, Mesenchymal

NCT03651375 2021-01-22

UN-RESARC

Phase 2 Unknown

46 enrolled

Sarcoma

Fibrosarcoma, Leiomyosarcoma, Liposarcoma, Lymphangiosarcoma, Myosarcoma, Sarcoma, Sarcoma, Synovial, Liposarcoma, Myxoid, Dermatofibrosarcoma, Neurofibrosarcoma, Histiocytoma, Malignant Fibrous, Histiocytic Sarcoma

NCT03397186 2019-09-10

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

Phase 2 Withdrawn

Sarcoma

Sarcoma, Liposarcoma, Myxoid

NCT03816475 2019-06-17

LIPOMYX

Phase 2 Unknown

35 enrolled

Sarcoma

Sarcoma, Liposarcoma, Myxoid

Clinical Trials

TRABEPIO

Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma

UN-RESARC

Immune Changes Following Trabectedin in Patients With Metastatic or Unresectable Sarcoma

LIPOMYX